Sanofi: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients
Sanofi: ASH: Sarclisa combinations demonstrated significant benefits …
3 个月之前
finanznachrichten.de
SARCLISA® (isatuximab-irfc) | How SARCLISA Works
SARCLISA® (isatuximab-irfc) | How SARCLISA Works
2020年9月17日
sarclisa.com
Sanofi: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
Sanofi: Sarclisa recommended for EU approval by the CHMP to treat …
4 个月之前
finanznachrichten.de
Sanofi: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
Sanofi: Sarclisa obtains first approval in China for the treatmen…
2 个月之前
finanznachrichten.de
ASCO: Sarclisa is the first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3; Sarclisa reduced the risk of recurrence or death by 40% versus VRd. | Industry Intelligence Inc.
ASCO: Sarclisa is the first anti-CD38 to significantly improve progressi…
5 个月之前
industryintel.com
#AskDrDurie: What does the FDA approval of Sarclisa® (isatuximab) mean for myeloma patients?
3:07
#AskDrDurie: What does the FDA approval of Sarclisa® (isatuximab…
已浏览 469 次2020年3月26日
FacebookInternational Myeloma Foundation
Sarclisa (isatuximab): a newly approved drug for treatment of multiple myeloma/ plasma cell myeloma
3:36
Sarclisa (isatuximab): a newly approved drug for treatment of m…
已浏览 662 次2020年3月8日
YouTubeMr. Lightyear
4:47
Dr. Tiffany Richards Explains a New Indication for Sarclisa in Newly Di…
已浏览 47 次2 个月之前
YouTubeMultiple Myeloma Research Foundation - MMRF
8:00
All About Sarclisa (Isatuximab) #myeloma
已浏览 818 次2021年8月26日
YouTubeHealthTree University for Multiple Myeloma
2:31
SARCLISA (isatuximab-irfc)- multiple myeloma
已浏览 26 次2023年9月25日
YouTubePharmacy Talk USA
3:30
FDA D.I.S.C.O. Burst Edition: FDA approval of Sarclisa (isatuximab-ir…
已浏览 50 次2024年4月2日
YouTubeU.S. Food and Drug Administration
1:14
How Does Isatuximab (SARCLISA) - VRd Improve PFS in Transplant-In…
已浏览 66 次10 个月之前
YouTubeOncologyTube
5:33
ASCO 2024 Top 5 SARCLISA Isatuximab + VRd Phase 3 IMROZ …
已浏览 315 次10 个月之前
YouTubeOncologyTube
7:19
What is Immunotherapy for Multiple Myeloma? Understanding Its Rol…
已浏览 1047 次7 个月之前
YouTubeInternational Myeloma Foundation
KStrategy& on LinkedIn: #sarclisa #sanofi #darzalex #janss…
6 个月之前
linkedin.com
10:37
Isatuximab, Lenalidomide, Bortezomib, and Dex for Newly-Di…
已浏览 575 次9 个月之前
YouTubeInternational Myeloma Foundation
Dr. Baljevic on the FDA Approval of the ICARIA-MM Regimen in Relap…
2021年9月16日
onclive.com
9:30
mRESVIA for Lower Respiratory Tract Disease, Breyanzi for R/R M…
已浏览 218 次10 个月之前
YouTubeNascent Medical
1:03:36
Latest Cancer Treatments in Relapsed/Refractory Multiple Myel…
已浏览 956 次2021年9月6日
YouTubeThe Patient Story
14:52
Module 7 – Case Study 4: MIDD to Establish Isatuximab Combinatio…
已浏览 264 次8 个月之前
YouTubeU.S. Food and Drug Administration
15:00
Multiple Myeloma Treatment: Past, Present and Future
已浏览 2179 次2020年6月5日
YouTubeStanley Kim
1:02:21
GPRC5D and FCRH5 Targeted Therapies in Myeloma
已浏览 1097 次2023年6月16日
YouTubeHealthTree Foundation
1:32
Highlighting Therapeutic Options in Later Lines for Multiple Myeloma
已浏览 113 次2020年8月6日
YouTubeTargeted Oncology
11:41
Multiple Myeloma - signs and symptoms, pathophysiology, treat…
已浏览 71.1万 次2015年7月23日
YouTubeArmando Hasudungan
Dr Lonial on the Outcomes of the IKEMA Trial in Relapsed Multiple …
2023年10月3日
onclive.com
1:59
SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022
已浏览 605 次2022年8月29日
YouTubeHealthTree Foundation
Dr. Weisel on the Safety Profile of Isa-KRd in High-Risk Multiple Mye…
2020年6月30日
onclive.com
Dr. Usmani on the Potential Future of Isatuximab in Multiple Myeloma
2021年4月26日
onclive.com
Dr. Martin on the Utility of Quadruplet-Based Regimens in R…
2021年9月10日
onclive.com
0:53
Dr Facon on the Implications of Isatuximab Plus VRd in Transplan…
已浏览 29 次8 个月之前
YouTubeOncLive
静态缩略图占位符